Arkolith/Insider Trading/OKYO/Form 4

Cerrone Gabriele M

Executive Chairman, DirectorOKYO Pharma Ltd (OKYO) · full profile →Form 4 · filed May 20, 2022
Net Buying
Open-Market Buys
$464K
Open-Market Sells
$0
Net Open-Market Flow
$464K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 19, 2022Buy(P)5.8M$0.08$464K549.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-014552) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML